SEC Form D · filed October 8, 2019
EYEGATE PHARMACEUTICALS INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (26)
Steven Boyd · Waltham, MADirectorStephen From · Waltham, MAExec · DirectorBernard Malfroy-Camine · Waltham, MADirectorMorton Goldberg · Waltham, MADirectorSarah Romano · Waltham, MAExecPraveen Tyle · Waltham, MADirectorThomas Hancock · Waltham, MADirectorPaul Chaney · Waltham, MADirectorRandy H. Hopkins · Meridian, IDDirectorJustin Jory · Woodbridge, VADirectorTom Bruderman · Redmond, WADirectorJay Lee · Redmond, WADirectorScott Fletcher · Ross, CADirectorRodney D. Brown · LEESBURG, VAExec · DirectorDaniel Wachtler · Redmond, WADirectorDavid Wurtzbacher · Woodbridge, VAExecPeter Greenleaf · New Haven, CTDirectorBrian Mcveigh · Hatfield, PADirectorJohn Iadeluca · New York, NYDirectorAccumulus Capital Partners, LLC · New York, NYDirectorSoutheast Asset Advisors, LLC · Thomasville, GADirectorAmir Nashat · CAMBRIDGE, MADirectorPaula Ragan · CAMBRIDGE, MADirectorRichard Young · CAMBRIDGE, MAExecJosh Mandel-Brehm · CAMBRIDGE, MAExec · DirectorPeter Greenleaf · Waltham, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗